Accenture
ACN
205.09
+8.45
+4.30%
Accenture
US · ACN
#182 by market cap
Listed 1970
205.09
+8.45
+4.30%
Live - 5344 symbols - heartbeat 118s ago
· 2026-10-08 15:09
Pre-market
198.00
+0.69%
After-hours
196.64
0.00%
Overnight
196.42
-0.11%
- Market cap
- 122.23B
- P/E (TTM)i
- 15.12
- P/Bi
- 3.87
- EPSi
- 13.56
- Div yieldi
- 3.18%
- 52W posi
- 52%
Reader sentiment
Are you bullish or bearish on ACN?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 8 years
Latest year +6.47% YoY
Margins
- Gross margin
- 32.05%
- Operating margin
- 15.38%
- Net margin
- 11.28%
Key ratios & quality
- Enterprise valuei
- 120.28B
- PEG ratioi
- 2.23
PEG uses trailing P/E against the 3-year net income growth rate (6.78%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG."
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 43.22B | 44.33B | 50.53B | 61.59B | 64.11B | 64.90B | 69.67B | 74.18B |
| Gross profit | 13.31B | 13.98B | 16.36B | 19.70B | 20.73B | 21.16B | 22.24B | 23.78B |
| Selling & admin expenses | 7.01B | 7.46B | 8.74B | 10.33B | 10.86B | 11.13B | 11.39B | 12.06B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 6.31B | 6.51B | 7.62B | 9.37B | 8.81B | 9.60B | 10.23B | 11.41B |
| Pretax profit | 6.25B | 6.77B | 7.76B | 9.20B | 9.14B | 9.70B | 10.27B | 11.37B |
| Tax | 1.41B | 1.59B | 1.77B | 2.21B | 2.14B | 2.28B | 2.44B | 2.85B |
| Net profit | 4.85B | 5.19B | 5.99B | 6.99B | 7.00B | 7.42B | 7.83B | 8.52B |
| Basic EPS | 7 | 8 | 9 | 11 | 11 | 12 | 12 | 14 |
| Diluted EPS | 7.36 | 7.89 | 9.16 | 10.71 | 10.77 | 11.44 | 12.15 | 13.56 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 17.73B | 17.60B | 18.74B | 18.04B | 18.72B | 18.68B |
| Gross profit | 5.83B | 5.61B | 6.20B | 5.46B | 6.13B | 5.98B |
| Selling & admin expenses | 2.84B | 2.95B | 3.02B | 2.97B | 2.96B | 3.12B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.98B | 2.05B | 3.18B | 2.49B | 3.18B | 2.86B |
| Pretax profit | 2.95B | 2.08B | 2.97B | 2.46B | 3.15B | 2.80B |
| Tax | 707.18M | 625.43M | 725.77M | 597.27M | 761.94M | 764.36M |
| Net profit | 2.24B | 1.45B | 2.24B | 1.86B | 2.39B | 2.03B |
| Basic EPS | 4 | 2 | 4 | 3 | 4 | 3 |
| Diluted EPS | 3.49 | 2.25 | 3.54 | 2.93 | 3.80 | 3.29 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 15.45B | 17.75B | 19.67B | 21.61B | 23.38B | 20.86B | 28.90B | 31.83B |
| Cash & ST investments | 6.13B | 8.51B | 8.17B | 7.89B | 9.05B | 5.01B | 11.48B | 12.84B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 29.79B | 37.08B | 43.18B | 47.26B | 51.25B | 55.93B | 65.39B | 73.60B |
| Total current liabilities | 11.06B | 12.66B | 15.71B | 17.52B | 18.01B | 18.98B | 20.35B | 22.30B |
| Short-term debt | 6.41M | 763.88M | 756.24M | 716.77M | 795.23M | 1.67B | 843.49M | 881.44M |
| Long-term debt | 16.25M | 54.05M | 53.47M | 45.89M | 43.09M | 78.63M | 5.03B | 10.00B |
| Total liabilities | 14,962,189,000.00 | 19,579,420,000.00 | 23,078,729,000.00 | 24,516,302,000.00 | 24,786,712,000.00 | 26,764,115,000.00 | 33,153,930,000.00 | 40,340,676,000.00 |
| Total equity | 14.83B | 17.50B | 20.10B | 22.75B | 26.46B | 29.17B | 32.24B | 33.26B |
| Retained earnings | 10.42B | 12.38B | 13.99B | 18.20B | 19.32B | 23.08B | 21.02B | -- |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 27.42B | 28.90B | 28.07B | 28.01B | 28.94B | 31.83B |
| Cash & ST investments | 9.64B | 11.48B | 9.66B | 9.41B | 10.17B | 12.84B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 63.36B | 65.39B | 64.70B | 67.06B | 68.81B | 73.60B |
| Total current liabilities | 18.77B | 20.35B | 19.90B | 20.96B | 21.61B | 22.30B |
| Short-term debt | 839.34M | 843.49M | 842.92M | 868.76M | 863.74M | 881.44M |
| Long-term debt | 5.04B | 5.03B | 5.03B | 5.03B | 5.03B | 10.00B |
| Total liabilities | 31,812,514,000.00 | 33,153,930,000.00 | 32,776,181,000.00 | 34,289,201,000.00 | 35,298,848,000.00 | 40,340,676,000.00 |
| Total equity | 31.55B | 32.24B | 31.92B | 32.78B | 33.51B | 33.26B |
| Retained earnings | 26.45B | 21.02B | 22.15B | 22.80B | 24.03B | -- |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 6.63B | 8.22B | 8.98B | 9.54B | 9.52B | 9.13B | 11.47B | 12.36B |
| Depreciation & amortization | 892.76M | 1.77B | 1.89B | 1.03B | 1.06B | 1.08B | 1.37B | 2.36B |
| Free cash flow | 6.03B | 7.62B | 8.40B | 8.82B | 9.00B | 8.61B | 10.87B | 11.62B |
| Dividends paid | -1.86B | -2.04B | -2.24B | -2.46B | -2.83B | -3.24B | -3.70B | -3.99B |
| Stock buybacks / issuance | -1.84B | -1.96B | -2.64B | -2.77B | -2.83B | -3.11B | -3.27B | -6.18B |
| Ending cash balance | 6.13B | 8.42B | 8.17B | 7.89B | 9.05B | 5.00B | 11.48B | 12.83B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | 3.68B | 3.91B | 1.66B | 3.82B | 3.79B | 3.10B |
| Depreciation & amortization | 292.01M | 497.10M | 296.03M | 314.44M | 307.94M | 603.41M |
| Free cash flow | 3.52B | 3.81B | 1.51B | 3.67B | 3.60B | 2.85B |
| Dividends paid | -923.89M | -921.73M | -1.01B | -1.01B | -995.33M | -974.47M |
| Stock buybacks / issuance | -1.29B | -317.78M | -1.86B | -1.39B | -731.50M | -2.19B |
| Ending cash balance | 9.63B | 11.48B | 9.65B | 9.40B | 10.17B | 12.83B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 38.58 | 32.52 | 32.34 | 33.04 | 28.75 | 26.92 | 25.82 | 26.66 |
| ROA %i | 17.62 | 15.28 | 14.72 | 15.21 | 13.95 | 13.56 | 12.66 | 12.04 |
| ROIC %i | 38.10 | 29.10 | 27.24 | 28.39 | 24.66 | 23.19 | 21.16 | 19.73 |
| 5-year avg ROE %i | 46.78 | 42.99 | 37.45 | 35.70 | 33.05 | 30.71 | 29.37 | -- |
| EBIT margin %i | 14.52 | 15.36 | 15.48 | 15.01 | 14.33 | 15.04 | 15.07 | 15.74 |
| FCF / sales %i | 13.95 | 17.18 | 16.61 | 14.32 | 14.03 | 13.27 | 15.61 | 15.66 |
| Current ratioi | 1.40 | 1.40 | 1.25 | 1.23 | 1.30 | 1.10 | 1.42 | 1.43 |
| Quick ratioi | 1.29 | 1.29 | 1.14 | 1.12 | 1.18 | 0.98 | 1.30 | 1.31 |
| Debt / assetsi | 0.08 | 9.40 | 8.12 | 7.04 | 6.15 | 7.37 | 12.51 | 18.20 |
| LT debt / equityi | 0.11 | 16.01 | 14.08 | 11.80 | 9.16 | 8.65 | 23.53 | 39.65 |
| Interest coveragei | 273.26 | 205.84 | 131.46 | 195.34 | 193.31 | 165.48 | 45.94 | 38.48 |
| Revenue CAGR (3Y) %i | 7.49 | 7.01 | 7.22 | 12.54 | 13.09 | 8.70 | 4.19 | 4.98 |
| Net income CAGR (3Y) %i | 5.14 | 14.03 | 13.31 | 12.90 | 10.39 | 7.14 | 3.74 | 6.78 |
| FCF CAGR (3Y) %i | 13.06 | 19.55 | 15.79 | 13.54 | 5.71 | 0.86 | 7.22 | 8.91 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 27.27 | 25.82 | 25.35 | 25.30 | 24.95 | 26.66 |
| ROA %i | 13.53 | 12.66 | 12.22 | 12.05 | 11.79 | 12.04 |
| ROIC %i | 22.16 | 21.16 | 19.72 | 19.69 | 19.53 | 19.73 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 15.64 | 15.07 | 14.91 | 14.86 | 14.93 | 15.74 |
| FCF / sales %i | 14.96 | 15.61 | 16.28 | 17.33 | 17.21 | 15.66 |
| Current ratioi | 1.46 | 1.42 | 1.41 | 1.34 | 1.34 | 1.43 |
| Quick ratioi | 1.32 | 1.30 | 1.29 | 1.20 | 1.21 | 1.31 |
| Debt / assetsi | 12.89 | 12.51 | 12.68 | 12.45 | 12.19 | 18.20 |
| LT debt / equityi | 23.98 | 23.53 | 23.84 | 23.96 | 23.60 | 39.65 |
| Interest coveragei | 57.86 | 45.94 | 39.97 | 40.77 | 41.06 | 38.48 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 15:09:54 · For reference only, not investment advice and not tailored to your situation.